The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2Council on Pharmacy and Chemistry (American Medical Association)
Science
The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2
Council on Pharmacy and Chemistry (American Medical Association)
Patent medicines
The innuendo that the Council discriminates in favor of certain
manufacturers, is itself a confession of weakness.
In publishing this correspondence the Council’s sole object is to put
the medical profession in possession of the exact facts of the case.
These may fairly be summed up as follows:
1. Secretogen was originally marketed as a preparation containing
secretin. None was found in it.
2. Notwithstanding proof of this fact, the G. W. Carnrick Company
retain the original name of the product, knowing that, by its
association with their former erroneous assertions concerning
Secretogen, this name must inevitably convey to a physician using
the product the impression that he is administering secretin. In the
advertising literature no hint is given that this original statement
was erroneous.
3. The product called “Secretogen” has not been shown, either
experimentally and by sound clinical evidence, to possess useful
therapeutic properties.
Under these circumstances the Council reaffirms its decision.--(_From
Reports of Council on Pharmacy and Chemistry, 1916, p. 72._)
IRON CITRATE GREEN
Report of the Council on Pharmacy and Chemistry
H. K. Mulford Company and E. R. Squibb and Sons submitted to the
Council ampules containing solutions of iron citrate green. It thus
became necessary to consider the eligibility of iron citrate green
itself for admission to New and Nonofficial Remedies. As the rules of
the Council provide that nonessential modifications of official or
nonproprietary preparations will not be recognized, the above named
firms were asked to state what advantages, if any, the so-called iron
citrate green had over the official iron and ammonium citrate. In reply
the H. K. Mulford Company wrote that it had come to the conclusion that
iron citrate green and ampules thereof would undoubtedly be considered
by the Council as a nonessential modification of an official product,
adding:
“It seems to differ from the official ferric citrate so far as
essentials go only in color, but custom, which is exceedingly hard
to change in South America, demands that this green variety of
ampules be used in place of the official product.”
In reply to a similar letter of inquiry E. R. Squibb and Sons wrote:
“Iron citrate green (iron and ammonium citrate green) differs from
the U. S. P. iron and ammonium citrate in that it contains less
iron and more citric acid and more ammonium citrate than does the
latter. It is of course a modification of the official salt and is
supplied to meet a real demand. Its reaction is quite decidedly
acid and our present stock contains Fe slightly below the U. S. P.
requirements for iron, assaying 15.74 per cent. instead of 16 per
cent. Fe. The tests used to control its quality are those for the
official product except as before indicated, it is always acid
instead of neutral, as the U. S. P. requires for that salt.”
Public-domain text, read in full here on John Shaqi.
Reviews
Reviews
No reviews yet
Be the first to share your thoughts on this work.
Elsewhere in the archive
Join the Discussion
Join the discussion
Sign in to leave a comment or review.
Sign InorCreate an account